{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:52:35Z","timestamp":1790826755217,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We investigated five single-nucleotide variants (SNVs) of the FN1 gene in female reproductive organ cancers. The proteins expressed by this gene are essential components of the extracellular matrix (ECM) that constitutes the tumor microenvironment (TME). The study group included 208 women diagnosed with cervical, uterine, and ovarian cancers and 208 age-matched cancer-free controls. Genomic DNA from whole blood was used to analyze five intronic SNVs of the FN1 gene using PCR\/RFLP. The results indicate that two of the studied FN1 gene variants may increase the risk of gynecological cancers in dominant and log-additive models (p = 0.048 and p = 0.040 for rs6725958, p = 0.033 and p = 0.038 for rs1968510, respectively). Comparing individual cancer groups with the controls, differences were observed for the ovarian cancer group (rs1968510 p = 0.015 and p = 0.016, rs6725958 p = 0.070 and p = 0.037 in dominant and log-additive models, respectively). None of these associations remained statistically significant after Bonferroni correction for multiple testing. Haplotype analyses revealed that the AGATC haplotype, containing minor alleles for rs35343655 and rs6725958, was more frequent in the entire gynecological cancer group (p = 0.0036). For individual cancer types, values of p = 0.0071 for ovarian, p = 0.0028 for endometrial, and p = 0.0269 for cervical cancers were obtained; Our preliminary study suggests that the rs6725958 and rs1968510 FN1 variants may slightly increase the risk of female reproductive system cancers, particularly ovarian cancer. These findings require further validation in larger, independent cohorts and functional studies.<\/jats:p>","DOI":"10.3390\/ijms27104302","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:04:36Z","timestamp":1778601876000},"page":"4302","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers\u2014A Preliminary Study"],"prefix":"10.3390","volume":"27","author":[{"given":"Piotr","family":"Pawlik","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, District Public Hospital in Poznan, Jurasz\u00f3w 7\/19, 60-479 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8986-7772","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Kurzawi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"},{"name":"Laboratory of Molecular Biology, Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2305-3116","authenticated-orcid":false,"given":"Marcin","family":"O\u017carowski","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants\u2014National Research Institute, Wojska Polskiego 71b, 60-630 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6599-9204","authenticated-orcid":false,"given":"Tomasz M.","family":"Karpi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Medical Faculty, Poznan University of Medical Sciences, Rokietnicka 10, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bogacz","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Poznan University of Medical Sciences, Rokietnicka Street 8, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7919-5005","authenticated-orcid":false,"given":"Piotr J.","family":"Olbromski","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, District Public Hospital in Poznan, Jurasz\u00f3w 7\/19, 60-479 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra E.","family":"Mrozikiewicz","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Treatment of Infertility, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-8238","authenticated-orcid":false,"given":"Maciej","family":"Br\u0105zert","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Treatment of Infertility, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw","family":"Markwitz","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Seremak-Mrozikiewicz","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"},{"name":"Laboratory of Molecular Biology, Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"OECD\/European Commission (2025). EU Country Cancer Profile: Poland 2025. EU Country Cancer Profiles, OECD Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/02652048.2025.2474457","article-title":"An update on nanoformulations with FDA approved drugs for female reproductive cancer","volume":"42","author":"Raj","year":"2025","journal-title":"J. Microencapsul."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","article-title":"Mechanisms of cancer metastasis","volume":"87","author":"Castaneda","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","article-title":"Update on Epithelial-Mesenchymal Plasticity in Cancer Progression","volume":"19","author":"Fontana","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e108647","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: A multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103129","DOI":"10.1016\/j.arcmed.2024.103129","article-title":"Identifying Genetic Profiles in Peripheral Blood Mononuclear Cells in Women with Polycystic Ovary Syndrome: An Observational Case-Control Study","volume":"56","author":"Heidarzadehpilehrood","year":"2025","journal-title":"Arch. Med. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.adcanc.2026.100178","article-title":"Integrative transcriptomic analysis of WNT\/TGF\u03b2-driven EMT pathways and drug-gene interaction networks in epithelial ovarian cancer","volume":"16","author":"Heidarzadehpilehrood","year":"2026","journal-title":"Adv. Cancer Biol. Metastasis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.seminoncol.2019.08.002","article-title":"Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications","volume":"46","author":"Rick","year":"2019","journal-title":"Semin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dalton, C.J., and Lemmon, C.A. (2021). Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling. Cells, 10.","DOI":"10.20944\/preprints202108.0010.v1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","article-title":"Fibronectin as a multiregulatory molecule crucial in tumor matrisome: From structural and functional features to clinical practice in oncology","volume":"40","author":"Spada","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-4-21","article-title":"Plasma and cellular fibronectin: Distinct and independent functions during tissue repair","volume":"4","author":"To","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1073\/pnas.80.11.3218","article-title":"Isolation and characterization of cDNA clones for human and bovine fibronectins","volume":"80","author":"Kornblihtt","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(83)90175-7","article-title":"Three different fibronectin mRNAs arise by alternative splicing within the coding region","volume":"35","author":"Schwarzbauer","year":"1983","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40364-025-00757-3","article-title":"Extracellular matrix: Unlocking new avenues in cancer treatment","volume":"13","author":"Lee","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Huaman, J., and Ogunwobi, O.O. (2020). Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG. Cells, 9.","DOI":"10.3390\/cells9071594"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hall, R.C., Vaidya, A.M., Schiemann, W.P., Pan, Q., and Lu, Z.R. (2023). RNA-Seq Analysis of Extradomain A and Extradomain B Fibronectin as Extracellular Matrix Markers for Cancer. Cells, 12.","DOI":"10.3390\/cells12050685"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhang, X., Xiahou, Z., Zhao, F., Wu, Q., Nie, W., and Wang, S. (2025). Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer. Front. Mol. Biosci., 12.","DOI":"10.3389\/fmolb.2025.1611964"},{"key":"ref_19","first-page":"111","article-title":"Role of FN1 and GREB1 gene polymorphisms in endometriosis","volume":"20","author":"Matalliotaki","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3892\/or.2014.3251","article-title":"A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer","volume":"32","author":"Kida","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12032-025-02754-w","article-title":"Role of the tumor microenvironment in cancer therapy: Unveiling new targets to overcome drug resistance","volume":"42","author":"Garemilla","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Aguilar-Cazares, D., Perez-Medina, M., Benito-Lopez, J.J., Galicia-Velasco, M., Meneses-Flores, M., Camarena, A., and Lopez-Gonzalez, J.S. (2026). The tumor microenvironment: Adding pieces to the puzzle. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1731338"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/s41598-025-91038-4","article-title":"Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme","volume":"15","author":"Liu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5561651","DOI":"10.1155\/2021\/5561651","article-title":"Fibronectin 1: A Potential Biomarker for Ovarian Cancer","volume":"2021","author":"Bao","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kujawa, K.A., Zembala-No\u017cy\u0144ska, E., Cortez, A.J., Kujawa, T., Kupryja\u0144czyk, J., and Lisowska, K.M. (2020). Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer. Cells, 9.","DOI":"10.3390\/cells9010149"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yoshida, S., Asanoma, K., Yagi, H., Onoyama, I., Hori, E., Matsumura, Y., Okugawa, K., Yahata, H., and Kato, K. (2021). Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07875-9"},{"key":"ref_27","first-page":"140","article-title":"Serum fibronectin levels in malignant and benign endometrial diseases","volume":"23","author":"Mitev","year":"2024","journal-title":"Przegl\u0105d Menopauzalny"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nebio\u011flu, A., Tanr\u0131verdi, R., Ba\u015farano\u011flu, M., Saylam, B., Ulusoy, E., Bozlu, M., Akbay, E., Tamer, L., and Erdo\u011fan, S. (2024). Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value. BMC Urol., 24.","DOI":"10.1186\/s12894-024-01592-8"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/nar\/gkac1198","article-title":"Optimized high-throughput screening of non-coding variants identified from genome-wide association studies","volume":"51","author":"Morova","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Giral, H., Landmesser, U., and Kratzer, A. (2018). Into the Wild: GWAS Exploration of Non-coding RNAs. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00181"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1093\/nar\/gkab924","article-title":"Prioritization of regulatory variants with tissue-specific function in the non-coding regions of human genome","volume":"50","author":"Dong","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_32","first-page":"65","article-title":"Gene polymorphisms of fibronectin rs2289202 and fibrillin 2 rs331069 associate with vascular disease, the TAMRISK study","volume":"8","author":"Kunnas","year":"2018","journal-title":"Biomed. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gr.137323.112","article-title":"Annotation of functional variation in personal genomes using RegulomeDB","volume":"22","author":"Boyle","year":"2012","journal-title":"Genome Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.4238\/2015.October.28.35","article-title":"Correlation between the development of calcium oxalate stones and polymorphisms in the fibronectin gene in the Uighur population of the Xinjiang region of China","volume":"14","author":"Murat","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1165\/ajrcmb.20.1.3232","article-title":"Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis","volume":"20","author":"Avila","year":"1999","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"W71","DOI":"10.1093\/nar\/gkm306","article-title":"Primer3Plus, an enhanced web interface to Primer3","volume":"35","author":"Untergasser","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000508558","article-title":"Power and Sample Size Calculations for Genetic Association Studies in the Presence of Genetic Model Misspecification","volume":"84","author":"Moore","year":"2019","journal-title":"Hum. Hered."},{"key":"ref_38","unstructured":"R Foundation for Statistical Computing (2025). R Core Team: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_39","unstructured":"Moreno, V., Gonzalez, J., and Pelegri, D. (2024). SNPassoc: SNPs-Based Whole Genome Association Studies, version 2.1-2, R Foundation for Statistical Computing."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: Analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4302\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:10:50Z","timestamp":1778602250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104302"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104302","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}